Literature DB >> 14811910

Direct splenic arterial and venous blood studies in the hypersplenic syndromes before and after epinephrine.

C S WRIGHT, C A DOAN, B A BOURONCLE, R M ZOLLINGER.   

Abstract

Entities:  

Keywords:  EPINEPHRINE; SPLEEN

Mesh:

Substances:

Year:  1951        PMID: 14811910

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  FELTY'S SYNDROME. RADIO-ACTIVE ISOTOPE STUDIES AND SPLENECTOMY.

Authors:  F B GIBBERD; C GILBERTSON; E M JEPSON
Journal:  Ann Rheum Dis       Date:  1965-01       Impact factor: 19.103

2.  Hypersplenism.

Authors:  W DAMESHEK
Journal:  Bull N Y Acad Med       Date:  1955-02

3.  [Changed activities of metabolic enyymes in thrombocytes of patients with liver cirrhosis and splenomegaly].

Authors:  H Goebell; H Bickel; C Bode; R Egbring; G A Martini
Journal:  Klin Wochenschr       Date:  1968-05-15

4.  Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.

Authors:  R H Aster
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  Sarcoidosis in children.

Authors: 
Journal:  Br Med J       Date:  1977-03-19

6.  Hyperventilation-induced changes of blood cell counts depend on hypocapnia.

Authors:  M Stäubli; F Vogel; P Bärtsch; G Flückiger; W H Ziegler
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

7.  Granulopoietic activity in Felty's syndrome.

Authors:  R Gupta; W A Robinson; D Albrecht
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

8.  Familial Felty's syndrome.

Authors:  L M Blendis; K L Jones; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

9.  Liver in Felty's syndrome.

Authors:  L M Blendis; I D Ansell; K L Jones; E Hamilton; R Williams
Journal:  Br Med J       Date:  1970-01-17

10.  Long-term outcome in Felty's syndrome.

Authors:  C Thorne; M B Urowitz
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.